Advertisement
UK markets close in 8 hours 5 minutes

  • FTSE 100

    8,074.67
    +29.86 (+0.37%)
     

  • FTSE 250

    19,798.22
    -1.50 (-0.01%)
     

  • AIM

    755.37
    +0.50 (+0.07%)
     

  • GBP/EUR

    1.1631
    +0.0004 (+0.03%)
     

  • GBP/USD

    1.2435
    -0.0017 (-0.14%)
     

  • Bitcoin GBP

    53,779.75
    +405.34 (+0.76%)
     

  • CMC Crypto 200

    1,417.63
    -6.47 (-0.45%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CRUDE OIL

    83.42
    +0.06 (+0.07%)
     

  • GOLD FUTURES

    2,336.30
    -5.80 (-0.25%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,185.39
    +356.46 (+2.12%)
     

  • DAX

    18,176.04
    +38.39 (+0.21%)
     

  • CAC 40

    8,100.25
    -5.53 (-0.07%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Dechra to buy Dutch firms AST Farma, Le Vet for 340 million euros

Reuters

(Reuters) - Veterinary firm Dechra Pharmaceuticals Plc (DPH.L) said it would buy the Netherlands-based AST Farma and Europe-focused Le Vet for 340 million euros (296.79 million pounds) in a cash and share deal.

The debt-free, cash-free deal will see Dechra paying about 75 percent in cash and 25 percent in new Dechra shares, and subject to a two year lock-in, Dechra said in a statement.

(Reporting By Justin George Varghese in Bengaluru; Editing by Gopakumar Warrier)